![Revati Shreeniwas](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Revati Shreeniwas
President chez
Revati, Inc.
Profil
Currently, Revati Shreeniwas is President at Revati, Inc. since 2004 and a Member at Continuing Medical Education, Inc. Formerly, Dr. Shreeniwas was Chief Medical Officer at Bright Minds Biosciences, Inc. from 2020 to 2022, Chief Medical Officer at NeurAxon Pharma, Inc. from 2015 to 2017, Vice President-Clinical Development at Soleno Therapeutics, Inc. from 2019 to 2020, Vice President-Clinical Research & Development at Alvine Pharmaceuticals, Inc., Principal at Scios, Inc., Principal at CV Therapeutics, Inc., Principal at The Trustees of Columbia University in The City of New York, Professor at Stanford University.
Postes actifs de Revati Shreeniwas
| Sociétés | Poste | Début |
|---|---|---|
Continuing Medical Education, Inc.
 Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Publishes medical magazines and journals | Corporate Officer/Principal | - |
Revati, Inc. | President | 01/01/2004 |
Anciens postes connus de Revati Shreeniwas
| Sociétés | Poste | Fin |
|---|---|---|
| BRIGHT MINDS BIOSCIENCES INC. | Directeur Technique/Scientifique/R&D | 01/12/2022 |
| SOLENO THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2020 |
NeurAxon Pharma, Inc.
 NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Directeur Technique/Scientifique/R&D | 01/01/2017 |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Revati, Inc. | |
Alvine Pharmaceuticals, Inc.
 Alvine Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Develops and commercializes therapeutics for inflammatory diseases | Health Technology |
Soleno Therapeutics, Inc.
 Soleno Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes novel therapeutics for the treatment of rare diseases | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Continuing Medical Education, Inc.
Continuing Medical Education, Inc. Publishing: Books/MagazinesConsumer Services Publishes medical magazines and journals | Consumer Services |
NeurAxon Pharma, Inc.
NeurAxon Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Researches and develops nervous system disorder therapies | Commercial Services |
Bright Minds Biosciences, Inc.
 Bright Minds Biosciences, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
